Non-peptidic αvβ3 antagonists containing indol-1-yl propionic acids

This publication has 16 references indexed in Scilit:

• Design, Synthesis, and Biological Evaluation of Novel Potent and Selective α_vβ₃/α_vβ₅ Integrin Dual Inhibitors with Improved Bioavailability. Selection of the Molecular Core
  Journal of Medicinal Chemistry, 2005
• Non-Peptide αvβ3 antagonists. Part 6: Design and synthesis of αvβ3 antagonists containing a pyridone or pyrazinone central scaffold
  Bioorganic & Medicinal Chemistry Letters, 2003
• Phenylbutyrates as potent, orally bioavailable vitronectin receptor (integrin αvβ3) antagonists
  Bioorganic & Medicinal Chemistry Letters, 2003
• Crystal Structure of the Extracellular Segment of Integrin αVβ3 in Complex with an Arg-Gly-Asp Ligand
  Science, 2002
• Nonpeptide αvβ3 antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptide
  Bioorganic & Medicinal Chemistry Letters, 2002
• Solid-Phase Synthesis of a Nonpeptide RGD Mimetic Library: New Selective αvβ3 Integrin Antagonists
  Journal of Medicinal Chemistry, 2001
• Ligands to the integrin receptor α_vβ₃
  Expert Opinion on Therapeutic Patents, 2000
• Cancer chemotherapeutics - angiogenesis agents: October 1999 - March 2000
  Expert Opinion on Therapeutic Patents, 2000
• Conversion of .alpha.-Keto Esters into .beta.,.beta.-Difluoro-.alpha.-keto Esters and Corresponding Acids: A Simple Route to a Novel Class of Serine Protease Inhibitors
  The Journal of Organic Chemistry, 1995
• Integrins: Versatility, modulation, and signaling in cell adhesion
  Cell, 1992